About Clínica Universidad de los Andes
"Clínica Universidad de los Andes busca entregar al paciente y su familia una atención de salud que respete su dignidad, resguarde su intimidad y contribuya a su bienestar físico y espiritual."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
2
Francisco Espinoza, MD
1
Genfit
1
Shin Poong Pharmaceutical Co. Ltd.
1
Sinovac Research and Development Co., Ltd.
1
Clinical Trials at Clínica Universidad de los Andes
During the past decade, Clínica Universidad de los Andes conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 1 clinical trials were completed, i.e. on
average, 16.7% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 1 clinical trials were completed. i.e. 25%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Assess Safety and Efficacy of Umbilical Cord-derived Mesenchymal Stromal Cells in Knee Osteoarthritis
2015-12-01
2017-04-01
Completed
30
A PHASE 2B PLACEBO-CONTROLLED, RANDOMIZED STUDY OF A RESPIRATORY SYNCYTIAL VIRUS (RSV) VACCINE IN PREGNANT WOMEN
2019-08-07
2021-09-30
Completed
1,153
A Trial to Evaluate the Efficacy and Safety of RSVpreF in Infants Born to Women Vaccinated During Pregnancy.
2020-06-17
2023-11-24
Active, not recruiting
14,750
Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)
2020-09-24
2028-12-01
Active, not recruiting
150
Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents
2021-09-10
2023-12-25
Active, not recruiting
14,000
The Efficacy and Safety of Pyramax in Mild to Moderate COVID-19 Patients (Phase3)
2021-10-18
2022-12-30
Recruiting
1,420
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Clínica Universidad de los Andes" #1 sponsor was "Pfizer" with 2 trials, followed by "Francisco Espinoza, MD" with 1 trials
sponsored, "Genfit" with 1 trials sponsored, "Shin Poong Pharmaceutical Co. Ltd." with 1 trials sponsored and "Sinovac Research and Development Co., Ltd."
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at Clínica Universidad de los Andes
According to Clinical.Site data, the most researched conditions in "Clínica Universidad de los Andes" are
"COVID-19" (2 trials), "Respiratory Tract Infection" (2 trials), "Osteoarthritis" (1 trials) and "Primary Biliary Cirrhosis" (1 trials). Many other conditions were trialed in "Clínica Universidad de los Andes" in a lesser frequency.
Clinical Trials Intervention Types at Clínica Universidad de los Andes
Most popular intervention types in "Clínica Universidad de los Andes" are "Biological" (4 trials) and "Drug" (3 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Controlled vaccine" (1 trials), "Elafibranor 80mg" (1 trials), "Hyaluronic Acid" (1 trials) and "Inactivated COVID-19 Vaccine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Clínica Universidad de los Andes
The vast majority of trials in "Clínica Universidad de los Andes" are
4 trials for "All" genders and 2 trials for "Female" genders.
Clinical Trials Status at Clínica Universidad de los Andes
Currently, there are NaN active trials in "Clínica Universidad de los Andes".
undefined are not yet recruiting,
1 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Clínica Universidad de los Andes,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Clínica Universidad de los Andes, 1 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".